Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvancePCS Banking On Mail Order Growth With Conversion Programs

Executive Summary

AdvancePCS expects mail order prescription volume to jump in 2004 with implementation of new contracts that encourage or mandate mail order use by patients

You may also be interested in...



Caremark/AdvancePCS Merger Will Give Company Half Medco’s Mail Capacity

Caremark will have about half of Medco's mail-order prescription capacity following the proposed acquisition of AdvancePCS

Caremark/AdvancePCS Merger Will Give Company Half Medco’s Mail Capacity

Caremark will have about half of Medco's mail-order prescription capacity following the proposed acquisition of AdvancePCS

Express Scripts Mail-Order Rx Penetration Could Double In 5 Years, Firm Says

Express Scripts plans to push the percentage of prescriptions filled by mail-order over 35% within the next five years, Chief Financial Officer George Paz told the recent SG Cowen healthcare conference in Boston

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel